These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9559288)

  • 1. Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder.
    Shapira NA; Keck PE; Goldsmith TD; McConville BJ; Eis M; McElroy SL
    Depress Anxiety; 1997; 6(4):170-3. PubMed ID: 9559288
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential for Drug-Drug Interactions with Adjunctive Tramadol Use in Treatment of Obsessive-Compulsive Disorder.
    Brown EE; Davies S
    Can J Psychiatry; 2016 May; 61(5):308-9. PubMed ID: 27254806
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid remission of OCD with tramadol hydrochloride.
    Goldsmith TB; Shapira NA; Keck PE
    Am J Psychiatry; 1999 Apr; 156(4):660-1. PubMed ID: 10200754
    [No Abstract]   [Full Text] [Related]  

  • 4. Obsessive-compulsive disorder: an open-label pilot trial of escitalopram.
    Galvão-de Almeida A; Quarantini LC; Góis CR; Santos-Jesus R; Miranda-Scippa AM; de Oliveira IR; da Silva Prado H; Leckman JF; Rosário MC
    CNS Spectr; 2007 Jul; 12(7):519-24. PubMed ID: 17603402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL; Potenza MN; McDougle CJ; Epperson CN
    J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible interaction of tramadol and antidepressants.
    Reus VI; Rawitscher L
    Am J Psychiatry; 2000 May; 157(5):839. PubMed ID: 10784494
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder.
    Storch EA; Goddard AW; Grant JE; De Nadai AS; Goodman WK; Mutch PJ; Medlock C; Odlaug B; McDougle CJ; Murphy TK
    J Clin Psychiatry; 2013 Jun; 74(6):e527-32. PubMed ID: 23842022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.
    Pessina E; Albert U; Bogetto F; Maina G
    Int Clin Psychopharmacol; 2009 Sep; 24(5):265-9. PubMed ID: 19629012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar effects of tramadol and venlafaxine in major depressive disorder.
    Reeves RR; Cox SK
    South Med J; 2008 Feb; 101(2):193-5. PubMed ID: 18364623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.
    Besiroglu L; Çetinkaya N; Selvi Y; Atli A
    Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series.
    Di Nicola M; Tedeschi D; Martinotti G; De Vita O; Monetta M; Pozzi G; Janiri L
    J Clin Psychopharmacol; 2011 Oct; 31(5):675-7. PubMed ID: 21881460
    [No Abstract]   [Full Text] [Related]  

  • 12. Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
    Friedman S; Abdallah TA; Oumaya M; Rouillon F; Guelfi JD
    J Clin Psychiatry; 2007 Jun; 68(6):972-3. PubMed ID: 17592930
    [No Abstract]   [Full Text] [Related]  

  • 13. Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram. A case report.
    Habermeyer B; Fuhr P; Hiss B; Alber C; Müller-Spahn F
    Pharmacopsychiatry; 2006 Sep; 39(5):193-4. PubMed ID: 16944412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.
    Koponen H; Lepola U; Leinonen E; Jokinen R; Penttinen J; Turtonen J
    Acta Psychiatr Scand; 1997 Nov; 96(5):343-6. PubMed ID: 9395151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-compulsive disorders due to neuroacanthocytosis treated with citalopram.
    Habermeyer B; Fuhr P
    Pharmacopsychiatry; 2007 Mar; 40(2):87. PubMed ID: 17447184
    [No Abstract]   [Full Text] [Related]  

  • 16. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder.
    Corá-Locatelli G; Greenberg BD; Martin J; Murphy DL
    J Clin Psychiatry; 1998 Sep; 59(9):480-1. PubMed ID: 9771822
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized, open-label pilot trial of selective serotonin reuptake inhibitors on neuropsychological functions in patients with obsessive compulsive disorder.
    Brar J; Sidana A; Chauhan N; Bajaj MK
    J Psychiatr Res; 2022 Jul; 151():439-444. PubMed ID: 35598501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of obsessive-compulsive disorder with venlafaxine.
    Grossman R; Hollander E
    Am J Psychiatry; 1996 Apr; 153(4):576-7. PubMed ID: 8599411
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder.
    Kochan LD; Qureshi AI; Fallon BA
    Curr Psychiatry Rep; 2000 Aug; 2(4):327-34. PubMed ID: 11122977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Venlafaxine in Selective Serotonin Reuptake Inhibitor-Resistant Obsessive-Compulsive Disorder: Experience From a Specialty Clinic in India.
    Balachander S; Kodancha PG; Arumugham SS; Sekharan JT; Narayanaswamy JC; Reddy YCJ
    J Clin Psychopharmacol; 2019; 39(1):82-85. PubMed ID: 30516575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.